首页> 中文期刊> 《中国卫生标准管理 》 >急性重型病毒性肝炎治疗体会

急性重型病毒性肝炎治疗体会

             

摘要

目的:对急性重型病毒性肝炎的治疗方法进行讨论。方法选取我院2015年1月~2016年1月所收治的47例急性重型病毒性肝炎患者作为研究对象,将47例患者分为对照组和研究组,两组进行对比实验。对照组采取常规疗法,治疗组采取综合疗措施。对两组患者谷丙转氨酶(ALT)、白蛋白(ALB)以及平均住院时间等指标进行观察,并对比分析两组重型病毒性肝炎的治疗效果。结果对照组ALT(471.87±120.56)µ/L、ALB(36.14±6.96)g/L,平均住院时间(53.3±10.2)d;治疗组ALT(2143.25±675.53)µ/L、ALB(28.16±4.22)g/L,平均住院时间为(34.8±9.7)d,两组患者之间差异具有统计学意义,P<0.05。结论对急性重型病毒性肝炎患者采取综合治疗方法能产生更好的治疗效果。%ObjectiveTo discuss the treatment method of acute severe viral hepatitis.Methods 47 cases of patients with acute severe viral hepatitis treated in our hospital from January 2015 to January 2016 were selected as study subjects,and 47 cases were divided into control group and study group. The two groups were compared with the experimental results. The control group was treated with routine therapy,and the treatment group was treated with combined therapy. The two groups of patients with alanine aminotransferase(ALT),albumin(ALB)as wel as the average length of stay and other indicators were observed,and the comparative analysis of two groups of severe viral hepatitis treatment effect.ResultsIn the control group,ALT(471.87±120.56)µ/L, ALB(36.14±6.96)g/L,the average hospitalization time(53.3±10.2)d,treatment group ALT(2 143.25±675.53)µ/L,ALB(28.16±4.22)g/L, the average hospitalization time was(34.8±9.7)d,between the two groups there was significant difference between patients with P<0.05. Conclusion The comprehensive treatment method for patients with acute severe viral hepatitis can produce better therapeutic effect.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号